Letter

Aspirin “resistance”

What is the risk of cardiovascular morbidity?

BMJ 2008; 336 doi: 10.1136/bmj.39479.465706.3A (Published 7 February 2008)
Cite this as: BMJ 2008;336:291.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter Elwood, honorary professor,
  2. Gareth Morgan, secretary, Welsh Aspirin Group
  1. 1Department of Primary Care and Public Health, Cardiff University Cardiff CF10 3XQ
  1. pelwood{at}doctors.org.uk

    The increased risk of vascular disease in a subgroup of patients judged to be “resistant” to aspirin led Krasopoulos et al to propose that there could be beneficial effect of aspirin of greater than 50% in aspirin sensitive patients.1

    The problem is identifying subjects “resistant” to aspirin. Krasopoulos et al accepted evidence from the authors of 20 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular